Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
|
CN |
|
I
|
International Workplace Group PLC
SWB:IWG
|
CH |
|
J
|
Jungheinrich AG
XHAN:JUN3
|
DE |
|
Sega Sammy Holdings Inc
F:RYU0
|
JP |
|
B
|
Broadridge Financial Solutions Inc
F:5B9
|
US |
|
E
|
East Asia Holdings Investment Ltd
KOSDAQ:900110
|
HK |
|
Tempest Therapeutics Inc
NASDAQ:TPST
|
US |
|
Hanjaya Mandala Sampoerna Tbk PT
F:HSZ
|
ID |
|
Meiho HoldingsInc
TSE:7369
|
JP |
|
N
|
Nerds On Site Inc
SWB:3NS
|
CA |
Bankruptcy Probability
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
J
|
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
|
1.5B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
665.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
391.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
371.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
253.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
175.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
189.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
131.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Jilin Province Huinan Changlong Bio-pharmacy Co Ltd has total debt of 547k CNY. This includes both short-term (0 CNY) and long-term (547k CNY) debt.
You can find a full breakdown on its Balance Sheet.